Sort
85,873 grants matching “alzheimers”
A Seamless Phase 2A-B Randomized Double Blind Placebo Controlled Trial to Evaluate the Efficacy and Safety of PQ 912 in Patients with Early Alzheimer's Disease
$2,494,955Howard Feldman · University Of California, San Diego · R01 · FY2023 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,493,850University Of Washington · P50 · FY2004 · AG
Assessing the role of cerebrovascular brain injury and dysfunction in Alzheimerâs disease pathogenesis in the BEACoN Cohort
$2,493,770Michael A Yassa · University Of California-Irvine · R01 · FY2025 · AG
Alzheimer's Disease Research Center
$2,492,346University Of California San Diego · P50 · FY2005 · AG
Clinical Core
$2,490,548Gabriel Alejandro De Erausquin · University Of Texas Hlth Science Center · U19 · FY2023 · AG
Circuit vulnerability of the lateral and medial entorhinal cortices in tauopathy models of Alzheimer's disease
$2,489,452Kei M Igarashi · University Of California-Irvine · RF1 · FY2025 · AG
Wisconsin Longitudinal Study - Initial Lifetime's Impact on Alzheimer's Disease and Related Dementias (WLS-ILIAD Study)
$2,488,576Sanjay Asthana · University Of Wisconsin-Madison · R01 · FY2022 · AG
Mild Cognitive Impairment: a Prospective Community Study
$2,488,494Mary Ganguli · University Of Pittsburgh At Pittsburgh · R01 · FY2017 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,488,133John Morris · Washington University · P50 · FY2011 · AG
Imaging Cerebral Small Vessels in Vascular Cognitive Impairment and Dementia (VCID)
$2,487,668Danny Jiong Jiong Wang · University Of Southern California · RF1 · FY2023 · AG
Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia
$2,487,017Michael Paasche-Orlow · Boston Medical Center · R01 · FY2021 · AG
Molecular Analysis Of Leukocyte Activation By Chemoattractants
$2,486,098Philip Murphy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Multiphoton Imaging of Thoughts of Food During Natural and Induced Hunger States
$2,485,888Mark L Andermann · Beth Israel Deaconess Medical Center · DP2 · FY2014 · DK
Analyzing Large-Scale Neuroimaging Data in Alzheimer's Disease
$2,485,857Pew-Thian Yap · Univ Of North Carolina Chapel Hill · RF1 · FY2016 · AG
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
$2,484,793Thomas M Wisniewski · New York University School Of Medicine · P01 · FY2020 · AG
Predictions and experimental validation of fold-switching proteins
$2,483,973Lauren Porter · National Library Of Medicine · ZIA · FY2025 · LM
Center for Mouse Genomic Variation at Single Cell Resolution
$2,483,575Seyed Ali Mortazavi · University Of California-Irvine · UM1 · FY2024 · HG
Center for Mouse Genomic Variation at Single Cell Resolution
$2,483,575Seyed Ali Mortazavi · University Of California-Irvine · UM1 · FY2025 · HG
Alzheimer's Disease Research Center
$2,483,534Murray A Raskind · University Of Washington · P50 · FY2008 · AG
Age-related changes of cognition in health and disease
$2,483,059Massachusetts General Hospital · P01 · FY2002 · AG
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
$2,482,205Jan Johansson · Artery Therapeutics, Inc. · R44 · FY2023 · AG
English Longitudinal Study of Ageing - Renewal 2024
$2,482,131Andrew Steptoe · University College London · R01 · FY2025 · AG
Defining the pathogenic relationship of TDP-43 inclusions and cytoplasmic double stranded RNA in AD and FTD
$2,481,834Mark W Albers · Harvard Medical School · RF1 · FY2022 · AG
Adversity, Aging and ADRD Risk among the Global Poor: A Biosocial Lifecourse Approach
$2,481,664Hans-Peter Kohler · University Of Pennsylvania · R01 · FY2023 · AG
Mechanisms of age-related tauopathy
$2,481,635John Fonda Crary · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · NS